Acura Pharma Cash Flow - Annual (OTCMKTS:ACUR)

Add to My Stocks
$0.4 $0 (0%) ACUR stock closing price Jun 22, 2018 (Closing)

The Acura Pharma cash flow statement is one of the three reports that the company generates every quarter. While its important to look at the Acura Pharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Acura Pharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Acura Pharma cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Acura Pharma had cash and cash equivalents of $2.48M at the beginning of the year and $5.18M at year end for 2016. ACUR increase in investments stood at a value of $10.79M for the latest year 2016.

View details of Acura Pharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Net Income Cash Flow
-7.38M-4.98M-13.2M-13.9M-9.66M10.38M-12.7M-15.83M14.47M
Depreciation Depletion Amortization Cash-Flow---------
Net Increase (Decrease) in Assets Liabilities--0.56M--1.37M--0.67M-0.66M-1.17M-21.35M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net-1.21M1.08M1.46M1.74M2.46M6.76M11.68M10.93M
Net Cash from (used by) Operating Activities
-5.56M-3.68M-11.04M-13.67M-7.03M12.31M-6.48M-5.2M4.19M
Increase (Decrease) in Prop Plant And Equipment-0.07M-0.2M-0.13M-0.02M-0.14M-0.13M-0.04M-0.22M-0.14M
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments10.87M-2.13M6.27M-19.98M--5.03M-5.03M
Other Cash Inflow (Outflow) from Investment Activities---2M------
Net Cash from (used by) Investment Activities
10.79M--6.25M-20.13M-0.13M-0.04M4.81M-5.18M
Issuance (Purchase) of Equity Shares-7.86M-3.33M-1.29M---
Issuance (Repayment) of Debt Securities-2.54M-1.96M-10M-----
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities--0.61M-0.52M-1.04M-1.04M-1.83M---
Net Cash from (used by) Financing Activities
-2.53M5.29M-0.52M12.28M-1.03M-0.54M---
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
2.69M1.71M-11.56M4.86M-28.2M11.64M-6.12M-0.22M-0.97M
Cash & Equivalents at Beginning of Year2.48M-12.34M7.47M35.68M24.04M30.17M30.39M31.36M
Cash & Equivalents at Year End5.18M2.48M-12.34M7.47M35.68M24.04M30.17M30.39M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Acura Pharma stock price history provides insight into historical stock price fluctuations, and Acura Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Acura Pharma saw a positive change in Net Change in Cash and Cash Equivalents of $2.69M in 2016. Apart from the Acura Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Acura Pharma reported a negative operating cash flow of $-5.56M for 2016 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: Acura Pharma generated $10.79M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash flow from financing activities shows the flow of cash between Acura Pharma and its owners and creditors and was $-2.53M for 2016. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Acura Pharma Cash Flow